Kingworld Medicines Group Ltd. Financial Overview
Kingworld Medicines Group Ltd.'s market cap is currently HK$327.51M. The company's EPS TTM is HK$-0.01; its P/E ratio is 55.10; and it has a dividend yield of 5.87%. Kingworld Medicines Group Ltd. is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
